Compulsory licensing for Covid vaccines not very attractive option; tech transfer is the key: Govt | India News – Times of India

New Delhi: Compulsory licensing for Kovid vaccines is not a very attractive option as it is not a ‘formula’ that matters and other aspects like raw material sourcing and human resource training should also be taken into consideration, the policy Commission member VK Paul said on Thursday.
Paul, president of the National Expert Group on Vaccine Administration for Kovid-19 (NEGVAC), said that technology transfer is the key and it is in the hands of the company that has done the R&D.
The government has faced criticism from various quarters over the lack of vaccines for Kovid among a country struggling with growing infection.
“Compulsory licensing is not a very attractive option because it is not a ‘formula’ that matters, but requires active participation, training of human resources, raw material sourcing and the highest level of biosafety laboratories,” he said. said.
Paul said, “In fact, we have gone one step beyond compulsory licensing and are ensuring an active partnership between Bharat Biotech and 3 other entities to increase production of covaxine.” He said that a similar arrangement is being followed for Sputnik.
On immunization of children, Paul said, “As of now, no country in the world is giving vaccines to children” and the World Health Organization has no recommendations to vaccinate children.
“There have been studies about the safety of vaccines in children, which has been encouraging. Trials in children in India are also going to start soon,” he said.
However, Paul said that the decision to vaccinate children should not be made on the basis of nervousness in WhatsApp groups and because some politicians want to do politics. “This decision has to be taken by our scientists after adequate data is available on the basis of tests,” he said.
Currently, three Kovid vaccines are used in India – Kovishield manufactured by Serum Institute, Kovaxin by Bharat Biotech and Russian-made Sputnik V. Till now, these vaccines are only approved for people 18 years of age and above.


Read More World News

Keep Reading Latest Breaking News

Source link


Leave a Comment